Lv11
30 积分 2023-03-24 加入
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
28天前
已完结
Directed evolution of human T-cell receptors with picomolar affinities by phage display
2个月前
已完结
Generation and Characterization of Mirikizumab, a Humanized Monoclonal Antibody Targeting the p19 Subunit of IL-23
3个月前
已完结
Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease
4个月前
已完结
IL‐4 and IL‐13 are not involved in IL‐31‐induced itch‐associated scratching behaviour in mice
4个月前
已完结
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
4个月前
已完结
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
4个月前
已完结
IL-31–generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin
4个月前
已完结
Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses
4个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
4个月前
已完结
皖公网安备34019202002308
